TITLE

Stem-Cell Breakthrough

AUTHOR(S)
Underwood, Anne
PUB. DATE
August 2009
SOURCE
Newsweek (Atlantic Edition);8/3/2009 (Atlantic Edition), Vol. 154 Issue 5, p48
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article examines developments in stem cell research. The world's first clinical trial will begin in 2009 on the use of embryonic stem cells to help repair damaged spinal cords. This reflects the expansion of research on the therapeutic use of stem cells from the replacement of damaged cells to the development of drugs and research on the biological origins of diseases.
ACCESSION #
43508566

 

Related Articles

  • Stem-Cell Breakthrough. Underwood, Anne // Newsweek (Pacific Edition);8/3/2009 (Pacific Edition), Vol. 154 Issue 5, p44 

    The article examines developments in stem cell research. The world's first clinical trial will begin in 2009 on the use of embryonic stem cells to help repair damaged spinal cords. This reflects the expansion of research on the therapeutic use of stem cells from the replacement of damaged cells...

  • Human iPS Cells: Science and Ethics. Crook, Jeremy Micah // Open Stem Cell Journal;2010 Special Issue, p1 

    An introduction to the journal is presented in which the editor discusses articles on the science and ethic of human induced pluripotent stem (iPS) cells, the human somatic cell reprogramming, and the biological equivalent of the iPS and embryonic stem (ES) cells.

  • Yamanaka factors critically regulate the developmental signaling network in mouse embryonic stem cells. Liu, Xiaosong; Huang, Jinyan; Chen, Taotao; Wang, Ying; Xin, Shunmei; Li, Jian; Pei, Gang; Kang, Jiuhong // Cell Research;Dec2008, Vol. 18 Issue 12, p1177 

    Yamanaka factors (Oct3/4, Sox2, Klf4, c-Myc) are highly expressed in embryonic stem (ES) cells, and their over-expression can induce pluripotency in both mouse and human somatic cells, indicating that these factors regulate the developmental signaling network necessary for ES cell pluripotency....

  • Stem Cells: Panacea or Pandora's Box? McCaffrey, Ryan M. // Harvard Salient;4/24/2008, p8 

    The article discusses the dispute over the issue of using human embryonic stem (ES) in research. The benefit of ES research is said to be infinite for the improvement of clinical treatments of various medical conditions. Critics of ES cell research argue that it is a degradation of human life...

  • Engineered embryonic stem cells for regnerative nedicine. Hescheler, J. // Cell Research;Aug2008 Supplement, Vol. 18, pS111 

    Due to their ability to reproduce the embryological differentiation of nearly all different cellular phenotypes, embryonic stem (ES) cells represent an ideal tool to study processes of embryogenesis under in vitro conditions, in particular the signalling cascades and genes involved in the...

  • Stem Cell Science: Current Ethical and Policy Issues. Mauron, A.; Jaconi, M. E. // Clinical Pharmacology & Therapeutics;Sep2007, Vol. 82 Issue 3, p330 

    There is increasing support for embryonic stem (ES) cell research on both sides of the Atlantic. In the United States, the outcome is more funding from non-federal sources, despite the current administration's opposing views. In Europe, a similar pragmatic turn is in the making, but the future...

  • Nuclear Magnetic Resonance Detects Phosphoinositide 3-Kinase/Akt-Independent Traits Common to Pluripotent Murine Embryonic Stem Cells and Their Malignant Counterparts. Romanska, Hanna M.; Tiziani, Stefano; Howe, Rachael C.; Günther, Ulrich L.; Gulzar, Zulfiqar; Lalani, El-Nasir // Neoplasia;Dec2009, Vol. 11 Issue 12, p1301 

    Pluripotent embryonic stem (ES) cells, a potential source of somatic precursors for cell therapies, cause tumors after transplantation. Studies of mammalian carcinogenesis using nuclear magnetic resonance (NMR) spectroscopy have revealed changes in the choline region, particularly increased...

  • Stem Cell Diversification. Hobson, Katherine // U.S. News & World Report;Aug2009, Vol. 146 Issue 7, p31 

    The article examines the decision of U.S. President Barack Obama to remove government policy that had restricted the use of embryonic stem cells in medical applications. While much progress has been made in the research of adult stem cells, embryonic cells still hold the most promise for...

  • Reality Check on an Embryonic Debate. Begley, Sharon; Interlandi, Jeneen // Newsweek;12/3/2007, Vol. 150 Issue 23, p52 

    The article reports on progress made in stem cell research and the successful research carried out by a team of Kyoto, Japan scientists at the University of Wisconsin-Madison who took human genes and reprogrammed them into becoming stem cells, eliminating the need for embryonic stem cells....

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics